MAFTIVIMAB

UNII:	KOP95331M4
Formula:
Preferred Substance Name:	MAFTIVIMAB

2135632-36-7
IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN) (HUMAN MONOCLONAL REGN3479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3479 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS (ZAIRE EBOLA VIRUS (EBOV)) GLYCOPROTEIN), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HOMO SAPIENS (1-448) (VH (HOMO SAPIENS IGHV3-23*04 (95.9%)-(IGHD)-IGHJ3*02(93.3%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (215) (119-216), HINGE (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (98.9%)-IGKJ5*01(91.7%)) (6.3.8) (1'-106')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (106'-213'))DIMER (227-227'':230-230'')-BISDISULFIDE
INMAZEB COMPONENT MAFTIVIMAB-EBGN
MAFTIVIMAB [INN]
MAFTIVIMAB [USAN]
MAFTIVIMAB [WHO-DD]
MAFTIVIMAB-EBGN
REGN3479
REGN-3479
REGN-EB3 COMPONENT MAFTIVIMAB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MAFTIVIMAB

Synonyms and Mappings

Resources